Contacts · НУХТ ↗ УКР EN
Department of
Biotechnology
and Microbiology
Apply 2026

An Inside Look at Pharmacovigilance

An Inside Look at Pharmacovigilance

Master’s education is not only such familiar lectures and practical classes in the Zoom videoconference format, but also a wonderful opportunity to communicate with specialists from leading pharmaceutical companies, diving deeper into the activities that await Master’s students after obtaining the coveted diploma. Indeed, as part of the course “Modern Pharmaceutical Technologies,” thanks to Yuri Karlash and with the support of Arterium Corporation, a series of training sessions was organized for first-year Master’s students. Specifically, the first training was devoted to examining the main tasks and nuances of how the pharmacovigilance system operates.

Each of us faces the need to purchase and consume pharmaceutical drugs almost daily. However, does anyone wonder how two-sided the process of ensuring the quality, effectiveness, and safety of medicines really is? That’s the point—because not only the manufacturer of the drug participates in this process, but also we, the consumers of the product. Pharmacovigilance is a science and practical activity related to the detection, analysis, understanding, and prevention of adverse reactions or any other problems associated with the use of medicines. Therefore, each consumer can directly influence the course of the life cycle of medicines by reporting one or another adverse effect during treatment.

The well-known Ukrainian pharmaceutical corporation “Arterium” pays significant attention to pharmacovigilance. Thus, Rimma Battalova, the pharmacovigilance manager, told students of group FB-1-2M in detail about the features and specific aspects of this process in the corporation. The pharmacovigilance system at Arterium Corporation is aimed at monitoring the safety of medicines and their effectiveness throughout the entire life cycle of the product. Identified adverse reactions or lack of effectiveness indicate the need for further study of such medicinal products. Modern technologies make it possible to monitor all cases of adverse reactions, not only in Ukraine, but throughout the world. This capability allows the company to respond quickly to all reports and promptly resolve these issues to minimize risks and harm to consumers.

During the presentation, students received information that was interesting to them not only as future employees of pharmaceutical enterprises, but also as consumers of pharmaceutical products. Ms. Rimma explained very clearly and interestingly that there are no completely safe medicines, and first of all, one should focus not on the number of adverse reactions published in the instructions, but on the benefit-to-risk ratio. At the end of the presentation, each student had the opportunity to get answers to all their questions regarding pharmacovigilance. Students were extremely pleased to hear a number of interesting real cases related to pharmacovigilance and ways to solve practical problems that had arisen before and may also arise in the future.

Master’s students are very grateful that such highly qualified specialists in their field are happy to share valuable knowledge and experience.

Kerner Alina, first-year Master’s student